[ad_1]
India’s first indigenously developed quadrivalent human papillomavirus vaccine (qHPV) for the prevention of cervical cancer will be launched in the next few months and will be affordable to all, minister of state for science and technology Jitender Singh announced on Thursday.
Singh said Covid-19 had raised awareness about preventive healthcare and the development of vaccines like the one against cervical cancer was a result of the efforts made by scientists for over a decade. It will be made part of the national vaccination programme in a few months, he added. The minister was speaking at an event that marked the scientific completion of the vaccine, implying that all R&D activities pertaining to the vaccine are complete. It has been developed by Pune-based Serum Institute of India and the department of biotechnology.
[ad_2]
Source link